Affibody molecules as engineered protein drugs

Frejd, Fredrik Y, Kim, Kyu-Tae·2017·Experimental & Molecular Medicine
DOI 10.1038/emm.2017.35

Cited by (226)

Items 101–200 of 226

  1. Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy
    Songhee Ham, Kyoung Ah Min, Jae Wook Yang, Meong Cheol Shin · 2017 · Archives of Pharmacal Research
  2. Alternative scaffolds in radionuclide diagnosis of malignancies
    Olga Bragina, Владимир Иванович Чернов, R. V. Zeltchan, Синилкин Иван Геннадьевич, A. A. Medvedeva, Maria Sergeevna Larkina · 2019 · Bulletin of Siberian Medicine
  3. The Impact of Glycerol on an Affibody Conformation and Its Correlation to Chemical Degradation
    Ingrid Ramm, Adrian Sanchez-Fernandez, Jaeyeong Choi, Christian Lång, Jonas Fransson, Herje Schagerlöf, Marie Wahlgren, Lars Nilsson · 2021 · Pharmaceutics
  4. Affibody Functionalized Beads for the Highly Sensitive Detection of Cancer Cell-Derived Exosomes
    Nima Sayyadi, Sareh Zhand, Sajad Razavi Bazaz, Majid Ebrahimi Warkiani · 2021 · International Journal of Molecular Sciences
  5. Investigation of native and aggregated therapeutic proteins in human plasma with asymmetrical flow field-flow fractionation and mass spectrometry
    Ingrid Ramm, Mats Leeman, Herje Schagerlöf, Ileana R. León, Alejandra Castro, Lars Nilsson · 2022 · Analytical and Bioanalytical Chemistry
  6. Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
    Ayman Abouzayed, Hanna Tano, Ábel Nagy, Sara S. Rinne, Fadya Wadeea, Sharmishtaa Kumar, Kristina Westerlund, Толмачев Владимир Максимилианович, Amelie Eriksson Karlström, Anna Orlova · 2020 · Pharmaceutics
  7. Revisiting the phosphotyrosine binding pocket of Fyn SH2 domain led to the identification of novel SH2 superbinders.
    Shuhao Li, Yang Zou, Dongping Zhao, Yuqing Yin, Jingyi Song, Ningning He, Huadong Liu, Dongmeng Qian, Lei Li, Haiming Huang · 2020 · Protein Science
  8. Fusion of enzymatic proteins: Enhancing biological activities and facilitating biological modifications
    Agnieszka Rybarczyk, Talha Sultan, Nazim Hussain, Hafiz Muhammad Husnain Azam, Safa Rafique, Jakub Zdarta, Teofil Jesionowski · 2025 · Advances in Colloid and Interface Science
  9. Albumin incorporation into recognising layer of HER2-specific magnetic nanoparticles as a tool for optimal targeting of the acidic tumor microenvironment
    Olga A. Kolesnikova, Elena N. Komedchikova, Svetlana D. Zvereva, Anastasiia S. Obozina, Olha V. Dorozh, I. B. Afanas’ev, Petr Ivanovich Nikitin, Elizaveta N. Mochalova, Maxim P. Nikitin, Victoria O. Shipunova · 2024 · Heliyon
  10. Emerging trends in bispecific antibody and scaffold protein therapeutics
    Petra Verdino, S. Atwell, Stephen J. Demarest · 2018 · Current Opinion in Chemical Engineering
  11. Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-ZHER2 affibody conjugate
    Bahman Moradipoodeh, Mostafa Jamalan, Majid Zeinali, Masood Fereidoonnezhad, Ghorban Mohammadzadeh · 2020 · Molecular Biology Reports
  12. Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma
    Saidu Kamara, Yanru Guo, Shanshan Mao, Xiaoxian Ye, Qingfeng Li, Maolin Zheng, Jinshun Zhu, Jing Zhang, Wangqi Du, Jun Chen et al. · 2021 · Applied Microbiology and Biotechnology
  13. Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants
    Wangqi Du, Peipei Jiang, Qingfeng Li, Wen He, Maolin Zheng, Jing Zhang, Yanru Guo, Jia Yang, Weixu Feng, Sisi Ye et al. · 2022 · Microbiology Spectrum
  14. Robust de novo design of protein binding proteins from target structural information alone
    Longxing Cao, Brian Coventry, Inna Goreshnik, Buwei Huang, Joon Sung Park, Kevin M. Jude, Iva Marković, Rameshwar U. Kadam, Koen H. G. Verschueren, Kenneth Verstraete et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  15. A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation
    Alessandro Mega, Aman Mebrahtu, Gustav Aniander, Eva Ryer, Annette E. Sköld, Anna Sandegren, Eva Backström Rydin, Johan Rockberg, Arne Östman, Fredrik Y. Frejd · 2023 · mAbs
  16. Optical microchips based on high-affinity recombinant protein binders—Human serum albumin detection in urine
    Alena Semerádtová, Marcel Štofik, Lucie Vaňková, Petr Malý, Ondřej Staněk, Jan Malý · 2018 · Sensors and Actuators B Chemical
  17. Hyperstable Synthetic Mini-Proteins as Effective Ligand Scaffolds
    Paul L. Blanchard, Brandon J. Knick, Sarah A. Whelan, Benjamin J. Hackel · 2023 · ACS Synthetic Biology
  18. Bright Red Bioluminescence from Semisynthetic NanoLuc (sNLuc)
    Francesco Russo, Beatrice Civili, Nicolas Winssinger · 2024 · ACS Chemical Biology
  19. The role of the size of affinity ligands in the detection and characterization of extracellular vesicles
    Cuong Viet Pham, Rocky Chowdhury, Shweta Patel, Haben Melke, Yingchu Hou, Huo Ying Xu, Lee Jia, Andrew Duan, Wei Duan, Dongxi Xiang · 2024 · Biosensors and Bioelectronics
  20. EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models
    Yanru Guo, Saidu Kamara, Jing Zhang, Wen He, Maolin Zheng, Ying Liu, Luqi Zhou, Jun Chen, Shanli Zhu, Lifang Zhang · 2023 · Frontiers in Cellular and Infection Microbiology
  21. Recent Advances in the Scaffold Engineering of Protein Binders
    Mohammad Karimi Baba Ahmadi, Seyed A. Mohammadi, Manoochehr Makvandi, morteza mamouei, Mohammad Rahmati, Hesam Dehghani, David W. Wood · 2020 · Current Pharmaceutical Biotechnology
  22. Characterization of binding between model protein GA-Z and human serum albumin using asymmetrical flow field-flow fractionation and small angle X-ray scattering
    Jaeyeong Choi, Marie Wahlgren, Vilhelm Ek, Ulla M. Elofsson, Jonas Fransson, Lars Nilsson, Ann E. Terry, Christopher A. G. Söderberg · 2020 · PLoS ONE
  23. Near-infrared PbS quantum dots functionalized with affibodies and ZnPP for targeted imaging and therapeutic applications
    Ali W. Al-Ani, Francesco Zamberlan, Lenny Ferreira, Tracey Dawn Bradshaw, Neil R. Thomas, Lyudmila Turyanska · 2021 · Nano Express
  24. Albumin-binding DARPins as scaffold improve the hypoglycemic and anti-obesity effects of exendin-4 in vivo
    Jinying Xia, Guosheng Gao, Changzhen Zhang, Jingjing Ying, Jianhui Li · 2023 · European Journal of Pharmaceutical Sciences
  25. Light-induced efficient and residue-selective bioconjugation of native proteins via indazolone formation
    An‐Di Guo, Ke-Huan Wu, Xiaohua Chen · 2021 · RSC Advances
  26. Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting
    Kristina Westerlund, Maryam Oroujeni, Maxime Gestin, Jacob Clinton, Alia Hani Binti Rosly, Hanna Tano, Anzhelika Vorobyeva, Anna Orlova, Amelie Eriksson Karlström, Толмачев Владимир Максимилианович · 2024 · ACS Pharmacology & Translational Science
  27. A bispecific immunotoxin (IHPP) with a long half-life targeting HER2 and PDGFRβ exhibited improved efficacy against HER2-positive tumors in a mouse xenograft model
    Rui Guo, Yun Yang, Di Zhang, Jiang Du, Xinxing Zhu, Yanli Liu, Fen Yang, Juntang Lin · 2020 · International Journal of Pharmaceutics
  28. Imaging of Metastatic Cancer Cells in Sentinel Lymph Nodes using Affibody Probes and Possibility of a Theranostic Approach
    Makoto Tsuchimochi, Haruka Yamaguchi, Kazuhide Hayama, Yasuo Okada, Tomoyuki Kawase, Takamasa Suzuki, Norio Tsubokawa, Noriaki Wada, Atsushi Ochiai, Satoshi Fujii et al. · 2019 · International Journal of Molecular Sciences
  29. Generation of a novel affibody molecule targeting Chlamydia trachomatis MOMP
    Mingyang Li, Wei Shi, Jia Yang, Qi Wang, Haiyan Dong, Jun Chen, Lifang Zhang, Shanli Zhu · 2021 · Applied Microbiology and Biotechnology
  30. Combating chemoresistance: Current approaches & nanocarrier mediated targeted delivery
    Siuli Shaw, Subrata K. Pore, Dutong Liu, Tushar Kumeria, Ranu Nayak, Sudeep Kumar Bose · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  31. Recent Progress on Affibody-Based Supramolecular Architectures: Moving from Monomeric Constructs to Multivalent Assemblies
    Hongfei Wang, Liqiang Wei, Chunyue Du, Antony Kam, Shining Loo · 2025 · Pharmaceuticals
  32. Development of a biosensor based on a new marine luciferase fused to an affibody to assess Her2 expression in living cells
    Laura Rodríguez de la Fuente, Irene Golán Cancela, Ánxela Estévez‐Salguero, Pablo Iglesias, José A. Costoya · 2022 · Analytica Chimica Acta
  33. An efficient site-selective, dual bioconjugation approach exploiting N-terminal cysteines as minimalistic handles to engineer tailored anti-HER2 affibody conjugates
    Ana Novak, Florian Kersaudy, Sylvie Berger, Séverine Morisset‐Lopez, François Lefoulon, Carlo Pifferi, Vincent Aucagne · 2023 · European Journal of Medicinal Chemistry
  34. Engineering the Mechanical Stability of a Therapeutic Complex between Affibody and Programmed Death-Ligand 1 by Anchor Point Selection
    Byeongseon Yang, Diego E. B. Gomes, Zhaowei Liu, Mariana Sá Santos, Jiajun Li, Rafael C. Bernardi, Michael A. Nash · 2024 · ACS Nano
  35. Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA–peptide conjugates
    Benjamin Brennecke, Beatrice Civili, Pramod M. Sabale, Sofía Barluenga, Benjamin Meyer, Nicolas Winssinger · 2025 · Proceedings of the National Academy of Sciences
  36. Biologic therapies and small molecules in the treatment of hidradenitis suppurativa
    Deša Tešanović Perković, Branka Marinović, Mara Tešanović, Zrinka Bukvić Mokoš · 2025 · Clinics in Dermatology
  37. A dimeric α-helical cell penetrating peptide mounted with an HER2-selective affibody
    Seung‐Eun Chong, Dong‐Hyun Lee, Jae Hoon Oh, Sunyoung Kang, Sejong Choi, So Hee Nam, Jaehoon Yu, Heebeom Koo, Yan Lee · 2021 · Biomaterials Science
  38. Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer
    Ziqi Li, Mariam Aboian, Xiaohua Zhu, Bernadette V. Marquez-Nostra · 2022 · Cancers
  39. An affibody-conjugated nanoprobe for IGF-1R targeted cancer fluorescent and photoacoustic dual-modality imaging
    Ran Sun, Yuyang Zhao, Yanan Wang, Qian Zhang, Ping Zhao · 2021 · Nanotechnology
  40. Interrogating the potential of helical aromatic foldamers for protein recognition
    Sunbum Kwon, Vasily Morozov, Lingfei Wang, Pradeep K. Mandal, Stéphane Chaignepain, Céline Douat, Ivan Huc · 2024 · Organic & Biomolecular Chemistry
  41. Effective in vivo delivery of diphtheria toxin using protein cage nanoparticles for targeted cancer therapy
    Soomin Eom, Seong Guk Park, Heejin Jun, Yunjung Kim, Hyun Bin Lee, Sebyung Kang · 2025 · Acta Biomaterialia
  42. Development of ZHPV16E7- granzyme B immunoaffitoxin: dual mechanisms targeting hpv16-positive cervical cancer through epithelial-mesenchymal transition inhibition and cell death
    Xiaochun Tan, Jiani Yang, Yanheng Li, Kairong Wan, Sicong Feng, Xishang Jing, Zhenyun Xie, Lifang Zhang, Wenshu Li · 2025 · Frontiers in Immunology
  43. Two‐Helix Supramolecular Proteomimetic Binders Assembled via PNA‐Assisted Disulfide Crosslinking
    Mateusz Imiołek, Nicolas Winssinger · 2022 · ChemBioChem
  44. Three-helix bundle and SH3-type barrels: autonomously stable structural motifs in small and large proteins
    K. Nikolsky, L. Kulikova, D. V. Petrovskiy, V. Rudnev, T. Butkova, K. Malsagova, A. Kopylov, A. Kaysheva · 2023 · Journal of Biomolecular Structure and Dynamics
  45. Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-Immunoglobulin Scaffold Proteins
    Johannes Winkler · 2018 · Nucleic Acid Therapeutics
  46. The Radiolabeled HER3 Targeting Molecules for Tumor Imaging.
    Sajjad Molavipordanjani, Seyed Jalal Hosseinimehr · 2021 · PubMed Central
  47. Affinity Sedimentation and Magnetic Separation With Plant-Made Immunosorbent Nanoparticles for Therapeutic Protein Purification
    Matthew J. McNulty, Anton Schwartz, Jesse Delzio, Kalimuthu Karuppanan, Aaron Jacobson, Olivia Hart, Abhaya M. Dandekar, Anatoli Giritch, Somen Nandi, Yuri Y. Gleba et al. · 2022 · Frontiers in Bioengineering and Biotechnology
  48. Recombinant and Synthetic Affibodies Function Comparably for Modulating Protein Release
    Jonathan Dorogin, Morrhyssey A. Benz, Cameron J Moore, Danielle S. W. Benoit, Marian H. Hettiaratchi · 2024 · Cellular and Molecular Bioengineering
  49. A Complementarity‐Based Approach to De Novo Binder Design
    Kateryna Maksymenko, Valeriia Hatskovska, M.P. Coles, Narges Aghaallaei, Natalia Pashkovskaia, Natalia Borbarán‐Bravo, Matteo Pilz, Philip Bucher, Mareike Volz, Joana Pereira et al. · 2025 · Advanced Science
  50. Near-Infrared Photoimmunotherapy Using a Protein Mimetic for EGFR-Positive Salivary Gland Cancer
    Haruka Yamaguchi, Takamasa Suzuki, Yasuo Okada, Junya Ono, Hiroto Sano, Akiko Banba, Hideyuki Sakata, Akihiro Ishikawa, Takao Morita · 2024 · International Journal of Molecular Sciences
  51. Intracellular delivery of proteins for live cell imaging
    Ban-Seok Jeong, Hwanhee C. Kim, Catherine M Sniezek, Stephanie Berger, Justin M. Kollman, David A. Baker, Joshua C. Vaughan, Xiaohu Gao · 2025 · Journal of Controlled Release
  52. Breaking the Silence of Tumor Response: Future Prospects of Targeted Radionuclide Therapy
    Chandan Kumar, Aanchal Udaynath Pareri, Arunkumar Singh Koijam · 2021 · Anti-Cancer Agents in Medicinal Chemistry
  53. Development of AI-designed protein binders for detection and targeting of cancer cell surface proteins
    Bianca Broske, Sophie C. Binder, Benjamin A. McEnroe, Tim Noah Kempchen, Caroline I. Fandrey, Julia M. Messmer, Elisabeth Tan, Peter Konopka, Dominic Ferber, Michelle C.R. Yong et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Functionalizing Nucleic Acids: Synthesis and Purification Strategies for Bioconjugates as Biomaterials
    Nico Alleva, Jian Zhang, David Y. W. Ng, Tanja Weil, Torsten John · 2025 · Small
  55. Novel pharmacotherapies and breakthroughs in psoriatic arthritis treatment
    Aiman Arraf, Fadi Kharouf, Dafna D. Gladman · 2025 · Expert Opinion on Pharmacotherapy
  56. Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery
    Ábel Nagy, Ayman Abouzayed, Panagiotis Kanellopoulos, Fredrika Landmark, Ekaterina Bezverkhniaia, Толмачев Владимир Максимилианович, Anna Orlova, Amelie Eriksson Karlström · 2024 · ACS Omega
  57. Restructuring Biologically Assembled Binding Protein-Biopolymer Conjugates toward Advanced Materials
    Deeptee Chandrashekhar Pande, Trung Hiếu Vũ, Yaoying Lu, Frank Sainsbury, Van Thanh Dau, Bernd H. A. Rehm · 2024 · ACS Applied Materials & Interfaces
  58. Protein and peptide nanostructures for drug and gene delivery
    Uma Maheswari Krishnan · 2020 · Elsevier eBooks
  59. Albumin-binding as a universal strategy for half-life extension
    Huanbo Tan, Michael Sattler, Peijian Zou · 2022 · Japan Journal of Research
  60. Radiolabeled Antibodies for Cancer Radioimmunotherapy
    Julie Rousseau, Joseph Lau, François Bénard · 2021 · Springer eBooks
  61. Homomultimer Strategy for Improvement of Radiolabeled Peptides and Antibody Fragments in Tumor Targeting
    Fatemeh Ebrahimi, Seyed Jalal Hosseinimehr · 2022 · Current Medicinal Chemistry
  62. Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging
    Joanna Maria Mierzwicka, Hana Petroková, Leona Raskova Kafkova, Petr Kosztyu, Jiří Černý, Milan Kuchař, Miloš Petřík, Kateřina Dvořáková Bendová, Kristýna Krasulová, Yaroslava Groza et al. · 2024 · Journal of Translational Medicine
  63. EGFR Affibody and PEG functionalized protein nanoparticles: Sustaining targeting and macrophage evasion
    Seonhye Jang, Heejin Jun, Soomin Eom, Sheng Zhao, Niren Murthy, Sebyung Kang, Hansol Kim · 2025 · International Journal of Biological Macromolecules
  64. Phased affinity-controlled delivery of vascular endothelial growth factor, fibroblast growth factor-2, and platelet derived growth factor enhances in vitro angiogenesis
    Justin E. Svendsen, Chandler L. Asnes, Samuel R. Nightheart, Madeleine R. Ford, Athena Hajarizadeh, Sang Cheul Oh, Henry B. Hochstatter, Johnathan R. O’Hara-Smith, Robert E. Guldberg, Marian H. Hettiaratchi · 2026 · Journal of Controlled Release
  65. Ga-68-Labeled Affibody Molecule-Based Radiopharmaceutical Targeting Platelet Derived Growth Factor Receptor Beta for Detection of Active Fibrosis in Patients with Myocardial Infarction
    Irina Velikyan, Karl‐Henrik Grinnemo, Viktor Flodin, Stefan Karl James, Ulrika Thelander, Michael Wagner, Sergey Rodin, Tanja Kero, Olle Korsgren, Olof Eriksson · 2025 · Pharmaceuticals
  66. A novel format of TNF-α binding affibody molecule ameliorate coronary artery endothelial injury in a mouse model of Kawasaki disease
    Jinshun Zhu, Huan Yu, L X Xie, Dujuan Shuai, Zhixian Huang, Yufei Chen, Chao Ni, Chang Jia, Xing Rong, Lifang Zhang et al. · 2024 · International Journal of Biological Macromolecules
  67. Alternative Binding Scaffolds: Multipurpose Binders for Applications in Basic Research and Therapy
    Doreen Könning, Jonas V. Schaefer · 2020 · Learning materials in biosciences
  68. Rapid, site-specific labeling of “off-the-shelf” and native serum autoantibodies with T cell–redirecting domains
    Fabiana Zappala, Elizabeth M. Higbee-Dempsey, Bian Jang, Joann M. Miller, Lesan Yan, Nicholas G. Minutolo, Gabriela T. Rosado-González, Andrew Tsourkas, Burcin Altun · 2022 · Science Advances
  69. Recent photoswitchable peptides with biological function
    V. T. Trinh, Olalla Vázquez · 2023 · Royal Society of Chemistry eBooks
  70. Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts
    Jie Zhang, Sara S. Rinne, Wen Yin, Charles Dahlsson Leitao, Elvira Björklund, Ayman Abouzayed, Stefan Ståhl, John Löfblom, Anna Orlova, Torbjörn Gräslund et al. · 2024 · ACS Pharmacology & Translational Science
  71. Light-responsive monobodies for dynamic control of customizable protein binding
    César Carrasco‐López, Evan M. Zhao, Agnieszka A. Gil, Nathan Alam, Jared E. Toettcher, José L. Avalos‬ · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Unlocking the power of affibody conjugated radioactive metallopharmaceuticals for targeted cancer diagnosis and therapy
    Dhanashree Murugan, Harashkumar Vasanthakumari Thirumalaiswamy, Vasanth Murugesan, Janarthanan Venkatesan, Unnikrishnan Balachandran, Kalaiarasu Lakshminarayanan, Drishty Satpati, Stefan R. Nikolić, Loganathan Rangasamy · 2025 · Pharmacology & Therapeutics
  73. SpyTag/SpyCatcher-ligated nanostructured lipid carriers for active mammary cancer targeting
    Min Kyung Sung, Jin Young Heo, Seonhye Jang, Hansol Kim, Youngdo Jeong, Sang-Jae Lee, Sung Tae Kim, Sung Tae Kim · 2025 · Journal of Industrial and Engineering Chemistry
  74. Bacterial toxins as immunomodulatory agents in cancer therapy
    Kantrol Kumar Sahu, N. Saleem Basha, Madhulika Pradhan, Sucheta, Akhilesh Dubey, Krishna Yadav · 2025 · Biochemical Pharmacology
  75. Bis‐ S ‐Glycosylation of Disulfides
    Shiyang Xu, Fei Hu, Shuoyingjie Wang, Weichen Wang, Yinqi Li, Zhiyao He, Rong Tian, Xia Zhang, Yingwei Wang, Dawen Niu · 2026 · Angewandte Chemie International Edition
  76. AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins
    Bianca Broske, Benjamin A. McEnroe, Sophie C. Binder, Tim Noah Kempchen, Caroline I. Fandrey, Elisabeth Tan, Dominic Ferber, Michelle C.R. Yong, Marie Kleinert, Julia M. Messmer et al. · 2026 · Nature Communications
  77. Genetic Algorithms Applied to Thermodynamic Rational Design of Mimetic Antibodies Based on the GB1 Domain of Streptococcal Protein G: An Atomistic Simulation Study
    Anderson A. E. Santo, Gustavo T. Feliciano · 2021 · The Journal of Physical Chemistry B
  78. A new trivalent recombinant protein for type 2 diabetes mellitus with oral delivery potential: design, expression, and experimental validation
    Maryam Ehsasatvatan, Bahram Baghban Kohnehrouz · 2024 · Journal of Biomolecular Structure and Dynamics
  79. Affibody-based molecular probe 99mTc-(HE)3ZHER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
    Xianwen Hu, Hongyu Hu, Dandan Li, Pan Wang, Jiong Cai · 2024 · Open Medicine
  80. 89Zr-Radiolabelling of p-NCS-Bz-DFO-Anti-HER2 Affibody Immunoconjugate: Characterization and Assessment of In Vitro Potential in HER2-Positive Breast Cancer Imaging
    Maria-Roxana Cornoiu, Radu M. Serban, Diana Cocioabă, Dragoș Andrei Niculae, Doina Drăgănescu, Radu Anton Leonte, Alina Catrinel Ion, Dana Niculae · 2025 · Pharmaceutics
  81. Mesoscale computational protocols for the design of highly cooperative bivalent macromolecules
    Suman Saurabh, Francesco Piazza · 2020 · Scientific Reports
  82. Emerging Trends, Challenges, and Opportunities in Protein Therapeutics
    Sasi Silpa, X. Janet Bertilla, S. Rupachandra · 2023 · Springer eBooks
  83. Radiolabeled Affibody Molecules for PET Imaging
    Chiara Da Pieve, Gabriela Krämer-Marek · 2023 · Methods in molecular biology
  84. Engineering high affinity antigen-binders: Beyond conventional antibodies
    Rajeev Kumar Pandey, Sanjana Mehrotra · 2024 · Advances in protein chemistry and structural biology
  85. 3-Methylpyrazole-Mediated C-Terminal Protein Modification
    Xinyue Zhang, Chunmao He · 2025 · Organic Letters
  86. Real-Time Binding Kinetics of Membrane Protein–Protein Interactions in a Membraneless Setting
    Y.-X. Wang, Yalun Wu, Lauren Ashley Mayse, Danny Capucilli, Po‐Jung Jimmy Huang, Sekar Ramachandran, Soching Luikham, Jeung‐Hoi Ha, Stewart N. Loh, Aaron J. Wolfe et al. · 2025 · Analytical Chemistry
  87. The effect of glycerol and protein structure on chemical degradation through deamidation and isomerization
    Ingrid Ramm, Carl Diehl, Amanda Västberg, Natalia Markova, Herje Schagerlöf, Marie Wahlgren, Lars Nilsson · 2025 · International Journal of Pharmaceutics
  88. A paired-agent fluorescent molecular imaging strategy for quantifying antibody drug target engagement in in vivo window chamber xenograft models
    Elif Kayaalp Nalbant, Cody C. Rounds, Negar Sadeghipour, Boyu Meng, Margaret R. Folaron, Chandrika Haldar, Rendall R. Strawbridge, Kimberley S. Samkoe, Scott C. Davis, Kenneth M. Tichauer · 2020
  89. Antibody proteomics
    L.Sh. Kazieva, Tatiana E. Farafonova, Victor Gavrilovich Zgoda · 2023 · Biomeditsinskaya Khimiya
  90. Advancements in Bispecific Antibody Development and Research Trends
    Yong Hwan Choi, Ha Seung Song, Su Keun Lee, Chi Hun Song, Ji Hoe Kim, Kyung Ho Han · 2023 · Microbiology and Biotechnology Letters
  91. PEG-modification enhances the targeted photothermal therapy of affibody-conjugated indocyanine green for precision cancer treatment
    Yanting Liu, Xuerui Bai, Henan Wang, Jian Wang, Shuang Li, Hongru Zhang, Fengwei Wang, Zhangyong Hong · 2024 · Biochemical and Biophysical Research Communications
  92. Targeted immunoPET imaging of multiple myeloma
    Gary A. Ulaner, Ola Landgren · 2025 · Seminars in Hematology
  93. Investigation of Antiblastic and Antibacterial Properties of Binuclear Platinum (II)-Interferon Conjugate
    Evgenii V. Plotnikov, Vladimir Plotnikov · 2022 · Current Bioactive Compounds
  94. The DARPin Encyclopedia: from Basic Research towards Therapeutics
    Philipp Sebastian Wild, Rohan Eapen, Patrik Forrer, Christian Jost · 2022 · Preprints.org
  95. The Inhibitory Effect of an HPV16E7-Specific Affibody Conjugated to Granzyme B (GrB) on Cervical Cancer Cells by Bifunctional Activity
    Jiani Yang, Yanheng Li, Kairong Wan, YU Li-jun, Fangfang Feng, Wenhuan Wang, Lifang Zhang, Wenshu Li · 2024 · Research Square
  96. Improving cyanobacteria productivity: From theory to assay
    Kiyan Shabestary · 2020 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  97. Biotherapeutics
    Edward D. Zanders · 2020 · Springer eBooks
  98. The DARPin Encyclopedia: from Basic Research Towards Therapeutics
    Philipp Sebastian Wild, Rohan Eapen, Patrik Forrer, Christian Jost · 2022 · Preprints.org
  99. Promising Developments in the Design of Protein Binders
    A Isidoro Cruz, Parisa Hosseinzadeh · 2022 · GEN Biotechnology
  100. The DARPin Encyclopedia: from Basic Research Towards Therapeutics
    Philipp Sebastian Wild, Rohan Eapen, Patrik Forrer, Christian Jost · 2022 · Preprints.org